Literature DB >> 29676274

Post-trial responsibilities beyond post-trial access.

Hae Lin Cho1, Marion Danis2, Christine Grady2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29676274      PMCID： PMC6010308          DOI： 10.1016/S0140-6736(18)30761-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  The Relationship of Health Insurance and Mortality: Is Lack of Insurance Deadly?

Authors:  Steffie Woolhandler; David U Himmelstein
Journal:  Ann Intern Med       Date:  2017-06-27       Impact factor: 25.391

2.  Health Insurance Coverage and Health - What the Recent Evidence Tells Us.

Authors:  Benjamin D Sommers; Atul A Gawande; Katherine Baicker
Journal:  N Engl J Med       Date:  2017-06-21       Impact factor: 91.245

Review 3.  The potential exploitation of research participants in high income countries who lack access to health care.

Authors:  Rafael Dal-Ré; Annette Rid; Ezekiel Emanuel; David Wendler
Journal:  Br J Clin Pharmacol       Date:  2016-02-29       Impact factor: 4.335
  3 in total
  5 in total

1.  Who should pay for the continuity of post-trial health care treatments?

Authors:  Roberto Iunes; Manuela Villar Uribe; Janet Bonilla Torres; Marina Morgado Garcia; Juliana Alvares-Teodoro; Francisco de Assis Acurcio; Augusto Afonso Guerra Junior
Journal:  Int J Equity Health       Date:  2019-06-03

Review 2.  Current challenges and opportunities in the care of patients with fibrodysplasia ossificans progressiva (FOP): an international, multi-stakeholder perspective.

Authors:  Robert J Pignolo; Christopher Bedford-Gay; Amanda Cali; Michelle Davis; Patricia L R Delai; Kristi Gonzales; Candace Hixson; Alastair Kent; Hope Newport; Manuel Robert; Christiaan Scott; Frederick S Kaplan
Journal:  Orphanet J Rare Dis       Date:  2022-04-18       Impact factor: 4.303

3.  End-of-Life Characteristics Associated With Short Hospice Length of Stay for Patients With Solid Tumors Enrolled in Phase I Clinical Trials.

Authors:  Ramy Sedhom; Amanda L Blackford; Arjun Gupta; Kelly Griffiths; Janet Heussner; Michael A Carducci
Journal:  J Natl Compr Canc Netw       Date:  2021-01-21       Impact factor: 11.908

4.  Experiences of Patients After Withdrawal From Cancer Clinical Trials.

Authors:  Connie M Ulrich; Kathleen Knafl; Anessa M Foxwell; Qiuping Zhou; Cynthia Paidipati; Deborah Tiller; Sarah J Ratcliffe; Gwenyth R Wallen; Therese S Richmond; Mary Naylor; Thomas F Gordon; Christine Grady; Victoria Miller
Journal:  JAMA Netw Open       Date:  2021-08-02

5.  Investigation of post-trial access views among study participants and stakeholders using photovoice and semistructured interviews.

Authors:  Nothando Ngwenya; Collins Iwuji; Nabeel Petersen; Nompilo Myeni; Samukelisiwe Nxumalo; Ursula Ngema; Janet Seeley
Journal:  J Med Ethics       Date:  2021-06-25       Impact factor: 5.926
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.